Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different ...
BARCELONA, Spain I March 13, 2025 I SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations ...
AZoLifeSciences on MSN1d
LncRNAs, CircRNAs, and the Unseen Regulators of Gene ExpressionLncRNAs and circRNAs are key regulators of gene expression, influencing disease mechanisms and offering potential as ...
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
A human-specific NOVA1 variant changed mouse vocalizations, potentially providing insights into the evolution of language.
Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...
Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that the company will present ...
As climate conditions become increasingly unpredictable, understanding how plants respond to cold is crucial for securing ...
Spliceosome structures have been investigated extensively in the past decade, but most of the studies have been restricted to ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback